UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (11), p.715-722

2008

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Bone marrow transplantation (Basingstoke), 2016-05, Vol.51 (5), p.654-662

2016

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.179-184

2014

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic SCT for patients with autoimmune diseases

Bone marrow transplantation (Basingstoke), 2009-07, Vol.44 (1), p.27-33

2009

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

Bone marrow transplantation (Basingstoke), 2016-09, Vol.51 (9), p.1184-1190

2016

Link zum Volltext

Verfügbarkeit prüfen

A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation

Bone marrow transplantation (Basingstoke), 1998-08, Vol.22 (3), p.307-309

1998

Link zum Volltext

Verfügbarkeit prüfen

Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

Bone marrow transplantation (Basingstoke), 2016-11, Vol.51 (11), p.1456-1463

2016

Link zum Volltext

Verfügbarkeit prüfen

Current status of blood and marrow transplantation for patients with AML

Bone marrow transplantation (Basingstoke), 2008-08, Vol.42 (S1), p.S14-S17

Messner, Ha

2008

Link zum Volltext

Verfügbarkeit prüfen

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

Bone marrow transplantation (Basingstoke), 2010-09, Vol.45 (9), p.1442-1448

2010

Link zum Volltext

Verfügbarkeit prüfen

The evolution of hematopoietic SCT in myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2009-04, Vol.43 (8), p.597-609

2009

Link zum Volltext

Verfügbarkeit prüfen

Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma

Bone marrow transplantation (Basingstoke), 2015-10, Vol.50 (10), p.1299-1305

2015

Link zum Volltext

Verfügbarkeit prüfen

Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies

Bone marrow transplantation (Basingstoke), 2015-12, Vol.50 (12), p.1526-1535

2015

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Bone marrow transplantation (Basingstoke), 2019-01, Vol.54 (1), p.44-52

2019

Link zum Volltext

Verfügbarkeit prüfen

Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.339-347

2010

Link zum Volltext

Verfügbarkeit prüfen

Influence of killer immunoglobulin-like receptor HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2008-04, Vol.41 (8), p.709-714

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma

Bone marrow transplantation (Basingstoke), 2012-10, Vol.47 (10), p.1318-1320

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma

Bone marrow transplantation (Basingstoke), 2008-10, Vol.42 (8), p.529-534

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1185-1191

2013

Link zum Volltext

Verfügbarkeit prüfen

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1573-1578

2016

Link zum Volltext

Verfügbarkeit prüfen

Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era

Bone marrow transplantation (Basingstoke), 2015-10, Vol.50 (10), p.1293-1298

2015

Link zum Volltext

Verfügbarkeit prüfen

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1409-1414

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (12), p.783-789

2008

Link zum Volltext

Verfügbarkeit prüfen

Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications

Bone marrow transplantation (Basingstoke), 1997-12, Vol.20 (12), p.1075-1080

1997

Link zum Volltext

Verfügbarkeit prüfen

Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2010-01, Vol.45 (1), p.31-37

2010

Link zum Volltext

Verfügbarkeit prüfen

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2006-09, Vol.38 (6), p.445-451

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaDevelopmental Biology

Zeitschrift / SerieBone Marrow Transplantation

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Biophysics
(28)
Hematology
(28)
Humans
(28)
Immunology
(28)
Life Sciences & Biomedicine
(28)
Oncology
(28)
Science & Technology
(28)
Transplantation
(28)
Adult
(27)
Female
(24)
Male
(23)
Aged
(20)
Care And Treatment
(20)
Stem Cell Transplantation
(18)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(16)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(16)
Graft-Versus-Host Reaction
(16)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The International Journal Of Developmental Biology
(1)

Menü

Weitere Dienste

Einstellungen

400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib

Allogeneic hematopoietic SCT for patients with autoimmune diseases

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

A case of EBV-associated lymphoproliferative disease following high-dose therapy and CD34-purified autologous peripheral blood progenitor cell transplantation

Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

Current status of blood and marrow transplantation for patients with AML

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

The evolution of hematopoietic SCT in myelodysplastic syndrome

Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma

Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention

Influence of killer immunoglobulin-like receptor HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation

Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma

Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma

Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications

Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

Aktive Filter

Suchergebnisse filtern